Prudential Financial
FUSN

Prudential Financial’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Prudential Financial’s Portfolio FUSN Stock Details FUSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,600
Closed -$44K – 2727
2022
Q3 		$44K Buy
+14,600
New +$36.5K ﹤0.01% 2567

Other funds holding FUSN

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Prudential Financial's FUSN Position: Q4 2022 in Review

Prudential Financial sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q4 2022, closing a stake of 14,600 shares — an estimated $44K sold.

Prudential Financial first reported a position in FUSN in Q3 2022 and held it in 1 quarter. The position peaked at $44K in Q3 2022. 30 funds tracked by Wall St. Rank hold FUSN as of Q4 2022.

  • Prudential Financial reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q4 2022 after selling out during the quarter.
  • Prudential Financial sold 14,600 Fusion Pharmaceuticals Inc. Common Shares shares in Q4 2022, an estimated $44K.
  • Prudential Financial first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2022 and held it in 1 quarter.
  • Prudential Financial's Fusion Pharmaceuticals Inc. Common Shares position peaked at $44K in Q3 2022.
  • 30 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q4 2022.

Based on Prudential Financial's 13F filing for Q4 2022, filed 14 Feb 2023.